Naphthalenyl derivatives for hitting P-gp/MRP1/BCRP transporters

被引:24
|
作者
Colabufo, Nicola A. [1 ]
Contino, Marialessandra [1 ]
Cantore, Mariangela [1 ,2 ]
Capparelli, Elena [1 ]
Perrone, Maria Grazia [1 ]
Cassano, Giuseppe [3 ]
Gasparre, Giuseppe [3 ]
Leopoldo, Marcello [1 ]
Berardi, Francesco [1 ]
Perrone, Roberto [1 ]
机构
[1] Univ Bari ALDO MORO, Dipartimento Farm, I-70125 Bari, Italy
[2] Natl Canc Inst, Clin Expt Oncol Lab, I-70124 Bari, Italy
[3] Univ Bari ALDO MORO, Univ Bari, Dipartimento Biosci Biotecnol & Sci Farmacol, I-70125 Bari, Italy
关键词
P-glycoprotein; Naphthalenyl derivatives; BCRP; MRP1; MDR revertant agents; MULTIDRUG-RESISTANCE; P-GLYCOPROTEIN; CANCER; INHIBITORS; MRP1; BCRP; RADIOTRACER; MODULATION; DESIGN; ASSAYS;
D O I
10.1016/j.bmc.2012.12.021
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Substituted naphthalenyl derivatives bearing oxazole, or thiazole or furyl heteronuclei have been carried out as bioisosters of aryl-oxazoles and -thiazoles derivatives previously reported in order to investigate the role of the hindrance on the activity towards P-gp/BCRP/and MRP1 transporters. In addition, the role of naphthalenyl group to modulate P-gp intrinsic activity of these compounds was ascertained. The results demonstrated that all naphthalenyl derivatives displayed comparable P-gp activity with respect to lead compounds previously characterized in our SAR studies but were less active towards BCRP and MRP1 pumps. In terms of intrinsic activity, the replacement of aryl with naphthalenyl moiety led to P-gp inhibitors, unambiguous or ambiguous substrates on the base of the heteronucleus and the substituent on the naphthalenyl fragment. Indeed, oxazole derivatives were: inhibitors (R = H, F, OH), unambiguous substrates (R = OCH3), or ambiguous substrate (R = Br); thiazole derivatives were: unambiguous substrates (R = OCH3, Br), or ambiguous substrates (R = H, F). Finally furyl derivatives were ambiguous substrates. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1324 / 1332
页数:9
相关论文
共 50 条
  • [21] Induction of the ABC-transporters Mdr1/P-gp (Abcb1), Mrp1 (Abcc1), and Bcrp (Abcg2) during establishment of multidrug resistance following exposure to mitoxantrone
    Nieth, C
    Lage, H
    JOURNAL OF CHEMOTHERAPY, 2005, 17 (02) : 215 - 223
  • [22] The effect of P-gp (Mdr1a/1b), BCRP (Bcrp1) and P-gp/BCRP inhibitors on the in vivo absorption, distribution, metabolism and excretion of imatinib
    Oostendorp, Roos L.
    Buckle, Tessa
    Beijnen, Jos H.
    van Tellingen, Olaf
    Schellens, Jan H. M.
    INVESTIGATIONAL NEW DRUGS, 2009, 27 (01) : 31 - 40
  • [23] Expression of multidrug resistance-related proteins P-gp, MRP1, and LRP in uterine sarcomas
    Yakirevich, E
    Naroditsky, I
    Sabo, E
    Lavie, O
    Sova, Y
    Resnick, MB
    MODERN PATHOLOGY, 2005, 18 : 209A - 209A
  • [24] Changes in Expression and Function of Placental and Intestinal P-gp and BCRP Transporters during Pregnancy
    Szatmari, Peter
    Ducza, Eszter
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (17)
  • [25] Expression of multidrug resistance-related proteins P-gp, MRP1, and LRP in uterine sarcomas
    Yakirevich, E
    Naroditsky, I
    Sabo, E
    Lavie, O
    Sova, Y
    Resnick, MB
    LABORATORY INVESTIGATION, 2005, 85 : 209A - 209A
  • [26] Induction effect of antiretroviral bictegravir on the expression of Abcb1, Abcg2 and Abcc1 genes associated with P-gp, BCRP and MRP1 transporters present in rat peripheral blood mononuclear cells
    Jadav, Tarang
    Rajput, Niraj
    Kumar, Hemant
    Behera, Santosh Kumar
    Sengupta, Pinaki
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2024, 20 (06) : 529 - 539
  • [27] Expression of P-glycoprotein (P-gp) and Multidrug Resistance Associated Protein 1(MRP1) in Canine Mammary Tumors
    Suzuki, T.
    Wangnaitham, S.
    Rungsipipat, A.
    15TH CONGRESS OF THE FEDERATION OF ASIAN VETERINARY ASSOCIATIONS, FAVA-OIE JOINT SYMPOSIUM ON EMERGING DISEASES, PROCEEDINGS, 2008, : P351 - P352
  • [28] Differential expression of ABC transporters (MDR1, MRP1, BCRP) in developing human embryos
    Konieczna, A.
    Erdoesova, B.
    Lichnovska, R.
    Jandl, M.
    Cizkova, K.
    Ehrmann, J.
    JOURNAL OF MOLECULAR HISTOLOGY, 2011, 42 (06) : 567 - 574
  • [29] The Interaction of Bortezomib with P-Gp, MRP-1 and BCRP Drug Transporters: Implications for Therapeutic Applications of Bortezomib in Advanced Multiple Myeloma and Other Neoplasias.
    Ooi, Melissa G.
    O'Connor, Robert
    Jakubikova, Jana
    Meiller, Justine
    Klippel, Steffen
    Delmore, Jake
    Kastritis, Efstathios
    McMillin, Douglas
    Clynes, Martin
    Richardson, Paul
    Mitsiades, Constantine S.
    O'Gorman, Peter
    Anderson, Kenneth C.
    BLOOD, 2009, 114 (22) : 688 - 689
  • [30] Role of the efflux transporters BCRP and MRP1 in human placental bio-disposition of pravastatin
    Afrouzian, Marjan
    Al-Lahham, Rabab
    Patrikeeva, Svetlana
    Xu, Meixiang
    Fokina, Valentina
    Fischer, Wayne G.
    Abdel-Rahman, Sherif Z.
    Costantine, Maged
    Ahmed, Mahmoud S.
    Nanovskaya, Tatiana
    BIOCHEMICAL PHARMACOLOGY, 2018, 156 : 467 - 478